Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Malcolm Roth

Plastic and Reconstructive Surgery Brooklyn, NY Medical Doctor

NPI 1598775884 CMS profile 27265

925 49Th St, 1St Floor, Brooklyn, NY 11219

Open in the dashboard

General payments

$24,755

79 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Malcolm Roth of Brooklyn, NY is reported in the CMS Open Payments database as having received $24,755 across 79 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,042 16
2024 General $3,438 13
2023 General $11,946 14
2022 General $2,779 13
2021 General $492 8
2020 General $448 8
2019 General $611 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Malcolm Roth
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Malcolm Roth were reported at $5,042. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Malcolm Roth Plastic and Reconstructive Surgery median Middle half National median
2019 $611 $335 $121–$1,264 $163
2020 $448 $162 $57–$417 $114
2021 $492 $245 $89–$735 $132
2022 $2,779 $325 $120–$932 $149
2023 $11,946 $343 $129–$999 $160
2024 $3,438 $390 $141–$1,085 $164
2025 $5,042 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. TELA Bio, Inc. $12,950 26 payments
  2. Musculoskeletal Transplant Foundation Inc. $6,917 12 payments
  3. Integra LifeSciences Corporation $2,142 9 payments
  4. Sientra, Inc. $633 10 payments
  5. Mentor Worldwide LLC $450 4 payments
  6. AxoGen $407 3 payments
  7. Becton, Dickinson and Company $387 1 payment
  8. Kerecis Limited $210 3 payments
  9. Davol Inc. $175 2 payments
  10. Endo Pharmaceuticals Inc. $139 1 payment
  11. Other $344 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $17,712 9 payments
  2. Food and Beverage $6,499 66 payments
  3. Travel and Lodging $544 4 payments
Products named General payments · program years 2019–2025
  1. OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) $10,006 18 payments
  2. OviTex 2S $2,852 7 payments
  3. SURGIMEND $1,765 5 payments
  4. CODMAN CERTAS $1,475 3 payments
  5. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $633 10 payments
  6. Avance Nerve Graft $407 3 payments
  7. AxoGuard Nerve Connector $407 3 payments
  8. AXOGUARD NERVE PROTECTOR $407 3 payments
  9. Axoguard HA+ Nerve Protector $407 3 payments
  10. AXOGUARD NERVE CAP $407 3 payments
  11. Other $4,971 56 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 37 billing codes

Paid by Medicare

$16,300

Medicare's payments for the services billed

Medicare patients

55

Average age 71

Services billed

152

30 women, 25 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 62%
Arthritis 36%
Cancer 33%
Diabetes 29%
Ischemic heart disease 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

79 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record